CYBN.NE

We’re living in interesting times and I mean that in the Chinese curse kind of way. We can’t seem to stop to catch our breath when it comes to…
Detroit, Michigan city officials announced on Monday that they had decriminalized psychedelics, becoming the latest municipality to pull back on law enforcement when it comes to plant-based mind-manifesting substances….
Interest in the psychedelic market is as high as Matt Gaetz and Joel Greenberg on a night out, but the accompanying FOMO has the potential to muddy the market,…
The psychedelics space is one of the hottest investment trips in the public markets today. Embryonic, wide open to possibility and with mounting scientific evidence of psychedelics’ healing properties,…
Revive Therapeutics (RVV.C) joined the AdvisorShares Psychedelics ETF (PSIL.NYSE) today, in time for its launch, according to a press release.   If you’re not entirely sure what an ETF…
Cruel, cruel summer It’s near the end of September and the seasons are changing.   Chet Hanks predicted this past summer would be a ‘white boy summer’. But for…
This week, news from the psychedelic sector has been dominated by patent applications and earnings being released. Here’s the run down of this week’s news. Cybin (CYBN.NE) It’s been…
Cybin (CYBN.NE) announced they are filing a new non-provisional patent application, their 14th patent application. The decision comes after what they called “a favourable international search report” relating to…
Doubling down on Cybin Back in January, Horizons’ (PYSK.NE) ETF held a relatively balanced portfolio of psychedelics companies. No company made up more than 10% of its holdings, with…